DICERNA PHARMACEUTICALS INC's ticker is DRNA and the CUSIP is 253031108. A total of 172 filers reported holding DICERNA PHARMACEUTICALS INC in Q4 2019. The put-call ratio across all filers is 1.21 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $321,000 | -82.4% | 15,908 | -67.4% | 0.01% | -81.0% |
| Q2 2021 | $1,821,000 | +40.0% | 48,806 | -4.1% | 0.06% | +31.8% |
| Q1 2021 | $1,301,000 | +55.1% | 50,897 | +33.6% | 0.04% | +57.1% |
| Q4 2020 | $839,000 | -4.0% | 38,095 | -21.6% | 0.03% | -12.5% |
| Q3 2020 | $874,000 | -30.0% | 48,591 | -1.2% | 0.03% | -33.3% |
| Q2 2020 | $1,249,000 | +21.6% | 49,186 | -12.0% | 0.05% | +20.0% |
| Q1 2020 | $1,027,000 | -31.1% | 55,912 | -17.4% | 0.04% | -16.7% |
| Q4 2019 | $1,491,000 | – | 67,662 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 1,355,392 | $29,859,000 | 6.21% |
| Bain Capital Life Sciences Investors, LLC | 3,080,237 | $67,858,000 | 4.26% |
| DAFNA Capital Management LLC | 587,756 | $12,948,000 | 3.85% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 227,388 | $5,009,000 | 2.91% |
| RTW INVESTMENTS, LP | 7,253,857 | $159,802,000 | 2.68% |
| Parkman Healthcare Partners LLC | 331,513 | $7,303,000 | 1.87% |
| Evolutionary Tree Capital Management, LLC | 60,864 | $1,341,000 | 1.02% |
| Eagle Health Investments LP | 69,000 | $1,520,000 | 0.97% |
| Woodline Partners LP | 1,358,796 | $29,934,000 | 0.79% |
| Affinity Asset Advisors, LLC | 40,000 | $881,000 | 0.47% |